...
首页> 外文期刊>Materials >In vitro and in vivo Biocompatibility of Alginate Dialdehyde/Gelatin Hydrogels with and without Nanoscaled Bioactive Glass for Bone Tissue Engineering Applications
【24h】

In vitro and in vivo Biocompatibility of Alginate Dialdehyde/Gelatin Hydrogels with and without Nanoscaled Bioactive Glass for Bone Tissue Engineering Applications

机译:含和不含纳米级生物活性玻璃的藻酸盐二醛/明胶水凝胶的体外和体内生物相容性,用于骨组织工程应用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In addition to good mechanical properties needed for three-dimensional tissue engineering, the combination of alginate dialdehyde, gelatin and nano-scaled bioactive glass (45S5) is supposed to combine excellent cellular adhesion, proliferation and differentiation properties, good biocompatibility and predictable degradation rates. The goal of this study was to evaluate thein vitro and in vivo biocompatibility as a first step on the way to its use as a scaffold in bone tissue engineering. In vitro evaluation showed good cell adherence and proliferation of bone marrow derived mesenchymal stem cells seeded on covalently crosslinked alginate dialdehyde-gelatin (ADA-GEL) hydrogel films with and without 0.1% nano-Bioglass®(nBG). Lactate dehydrogenase (LDH)- and mitochondrial activity significantly increased in both ADA-GEL and ADA-GEL-nBG groups compared to alginate. However, addition of 0.1% nBG seemed to have slight cytotoxic effect compared to ADA-GEL. In vivo implantation did not produce a significant inflammatory reaction, and ongoing degradation could be seen after four weeks. Ongoing vascularization was detected after four weeks. The good biocompatibility encourages future studies using ADA-GEL and nBG for bone tissue engineering application.
机译:除三维组织工程所需的良好机械性能外,藻酸盐二醛,明胶和纳米级生物活性玻璃(45S5)的结合还应具有出色的细胞粘附性,增殖和分化特性,良好的生物相容性和可预测的降解速率。这项研究的目的是评估其体外和体内生物相容性,以此作为在骨组织工程中用作支架的第一步。体外评估显示,在含和不含0.1%nano-Bioglass ®(nBG)的共价交联海藻酸二醛-明胶(ADA-GEL)水凝胶膜上接种的骨髓间充质干细胞均具有良好的细胞粘附性和增殖能力。 。与藻酸盐相比,ADA-GEL和ADA-GEL-nBG组的乳酸脱氢酶(LDH)和线粒体活性均显着增加。但是,与ADA-GEL相比,添加0.1%nBG似乎具有轻微的细胞毒性作用。体内植入未产生明显的炎症反应,并且在四周后可见持续的降解。四周后检测到持续的血管形成。良好的生物相容性鼓励将来使用ADA-GEL和nBG在骨组织工程应用中进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号